Streetbeat News

Products Services

PCSA

Processa Pharmaceuticals Inc (NASDAQ:PCSA) saw its shares surge 148.8% to close at $5.10 on Thursday. The company announced a public offering of 1.56 million shares and warrants at $4.50, aiming to raise $7.0 million. Following the offering, the stock traded lower on high volume. Processa also completed a Phase 1b trial for NGC-Cap, selecting two dosage regimens for a Phase 2 trial in advanced breast cancer. On Monday, the stock began trading on a reverse split basis of 1-for-20, and on Friday, shares dropped 23.9% to $3.88 in premarket trading.

Portfolio Pulse from Vandana Singh

January 26, 2024 | 4:16 pm

ALV

Autoliv, Inc. (NYSE:ALV) reported an 18% increase in Q4 FY23 sales to $2.751 billion, with adjusted EPS of $3.74 surpassing estimates of $3.27. Growth was seen in all regions except China, attributed to new product launches and higher prices. Adjusted operating margin improved to 12.1%, and operating income rose 43% to $334 million. The company anticipates repeating past seasonality in 2024 and expects FY24 organic sales growth of 5% and operating cash flow of around $1.2 billion. ALV shares rose 4.97% to $108.76.

Portfolio Pulse from Nabaparna Bhattacharya

January 26, 2024 | 4:01 pm

PBLA

Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares surged on heavy trading volume, significantly exceeding its 100-day average. The spike follows the company's announcement of reaching 50% enrollment for its Aspire global clinical trial for metastatic pancreatic cancer treatment. The small float of 480,324 shares post a 1-for-20 reverse split may also be amplifying the stock's movement.

Portfolio Pulse from Erica Kollmann

January 26, 2024 | 4:01 pm

DOGEUSD

Developer Mini Doge has launched the Doom video game on the Dogecoin blockchain using Inscriptions Technology, celebrating the game's 30th anniversary. This has led to a 103.4% surge in Dogecoin transactions and an increase in active addresses. Elon Musk hinted at integrating Dogecoin into the payment ecosystem of his company X, and analysts are optimistic about Dogecoin's future performance.

Portfolio Pulse from Khyathi Dalal

January 26, 2024 | 3:56 pm

BMI

Badger Meter, Inc (NYSE:BMI) reported a 24% year-on-year increase in Q4 2023 sales to $182.44 million, slightly above consensus estimates. Utility water sales rose 28% with strong demand for digital smart water solutions. Gross margin improved to 39.2%, and operating margin increased to 17.6%. EPS was $0.84, above the $0.82 consensus. The company has a strong cash position and is confident in future growth. However, BMI shares fell 7.16% to $141.41.

Portfolio Pulse from Anusuya Lahiri

January 26, 2024 | 3:46 pm

COIN

Oppenheimer upgraded Coinbase Global (NASDAQ:COIN) to an Outperform rating with a price target of $160. The upgrade is based on the expectation that Coinbase will have a favorable outcome in its legal battle with the SEC, citing recent legal precedents and the SEC's regulatory scope. The introduction of a spot Bitcoin ETF is seen as less competitive due to Coinbase's diverse offerings. Positive earnings per share are expected for Q4 2023 or early 2024, supported by increased trading volume. The report highlights potential catalysts for growth, including market share gains, premium pricing, new crypto ETF products, international expansion, and a strong financial base.

Portfolio Pulse from Murtuza Merchant

January 26, 2024 | 3:44 pm

CL

Colgate-Palmolive Company (NYSE:CL) surpassed Q4 FY23 sales expectations with a 7% increase to $4.95 billion and achieved a non-GAAP EPS of $0.87, beating estimates of $0.80. Gross profit margins rose by 400 basis points to 59.6%. The company plans to increase brand investment in 2024 after a 19% rise in advertising spending in 2023. Colgate holds a 41.1% global market share in toothpaste and 31.5% in manual toothbrushes. The FY24 outlook anticipates 1%-4% net sales growth and 3%-5% organic sales growth, with a forecast for gross profit margin expansion and mid to high-single-digit EPS growth. CL shares rose 2.05% to $82.89.

Portfolio Pulse from Nabaparna Bhattacharya

January 26, 2024 | 3:26 pm

VERA

Vera Therapeutics' stock price increased following the release of positive data from its Phase 2b ORIGIN clinical trial. Additionally, Raymond James upgraded Vera Therapeutics to Strong Buy.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 3:25 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

Market Clubhouse Morning Memo provides daily trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA based on a proprietary formula considering price, volume, and options flow. The memo outlines potential bullish and bearish price levels for each asset and advises traders to monitor these stocks for breakouts or reversals. The memo also notes the release of key economic data and suggests that larger funds may position trades ahead of the FOMC rate decision.

Portfolio Pulse from RIPS

January 26, 2024 | 3:16 pm

BTCUSD

Macro analyst Lyn Alden rated Bitcoin's health as A-, citing its 'highly investable' status based on five metrics: market capitalization and liquidity, increasing convertibility, the Lindy effect indicating longevity, improving user experience, and resistance to being banned. Alden's positive outlook is contingent on Bitcoin's price continuing to make higher highs and lows over several years amidst rising global liquidity.

Portfolio Pulse from Ivan Crnogatić

January 26, 2024 | 3:14 pm